A nurse is teaching a patient about a medication that alters sympathetic nervous system functions. To evaluate understanding, the nurse asks the patient to describe which functions the sympathetic nervous system regulates. Which answer indicates the need for further teaching?

Choice A: Metabolic Acid Deficit (Metabolic Alkalosis)

Vomiting or continuous nasogastric suctioning leads to the loss of gastric contents, which are rich in hydrochloric acid (HCl)1. This loss results in a decrease in the body’s acid levels, leading to a condition known as metabolic alkalosis2. Metabolic alkalosis is characterized by an increase in blood pH due to the loss of hydrogen ions (H+) and an increase in bicarbonate (HCO3-) levels. This condition can cause symptoms such as muscle twitching, hand tremors, and light-headedness.

Choice B: Carbonic Acid Excess (Respiratory Acidosis)

Carbonic acid excess, or respiratory acidosis, occurs when there is an accumulation of carbon dioxide (CO2) in the blood, leading to a decrease in blood pH3. This condition is typically caused by respiratory issues such as hypoventilation, chronic obstructive pulmonary disease (COPD), or severe asthma. It is not directly related to vomiting or nasogastric suctioning, which primarily affect the metabolic component of acid-base balance.

Choice C: Metabolic Acid Excess (Metabolic Acidosis)

Metabolic acidosis is characterized by a decrease in blood pH due to an accumulation of metabolic acids or a loss of bicarbonate. Common causes include renal failure, diabetic ketoacidosis, and severe diarrhea. Vomiting or nasogastric suctioning, which result in the loss of gastric acid, do not lead to metabolic acidosis but rather to metabolic alkalosis.

Choice D: Carbonic Acid Deficit (Respiratory Alkalosis)

Respiratory alkalosis occurs when there is a decrease in carbon dioxide levels in the blood, leading to an increase in blood pH. This condition is often caused by hyperventilation due to anxiety, fever, or high altitude. It is not related to the loss of gastric contents through vomiting or nasogastric suctioning, which primarily affect the metabolic component of acid-base balance.

Choice A Reason:

Inducer medications do not increase the blood level of newly added medications. Instead, they enhance the activity of enzymes that metabolize drugs, leading to a faster breakdown and lower concentration of the new medication in the bloodstream. This can result in reduced efficacy of the newly added medication.

Choice B Reason:

Inducer medications increase the activity of enzymes, particularly those in the cytochrome P450 family, which are responsible for drug metabolism. This increased enzyme activity accelerates the breakdown of the newly added medication, thereby decreasing its blood level and potentially reducing its therapeutic effect. For example, rifampin is a well-known inducer that can significantly lower the levels of drugs metabolized by CYP3A4.

Choice C Reason:

Inducer medications do not increase the half-life of newly added medications. On the contrary, by enhancing the metabolic activity of enzymes, they typically reduce the half-life of the new medication. This means the drug is broken down and eliminated from the body more quickly.

Choice D Reason:

Inducer medications do have a significant effect on new medications. They alter the metabolism of drugs by increasing the activity of metabolic enzymes, which can lead to decreased blood levels and reduced effectiveness of the new medication. Ignoring this interaction can result in subtherapeutic drug levels and treatment failure.